ENO2 sustains cancer stemness and metastatic competence through a phosphoenolpyruvate-dependent metabolic axis in triple-negative breast cancer.

Wang CH, Mai RT, Khoo KJ, Hung CF, Yang CK, Wu MJ, Chao CH

Open source

DOI
10.1038/s41419-026-09106-0
Published
2026 Jul 11
Container
Cell death & disease
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41419-026-09106-0,
  title = {ENO2 sustains cancer stemness and metastatic competence through a phosphoenolpyruvate-dependent metabolic axis in triple-negative breast cancer.},
  author = {Wang CH and Mai RT and Khoo KJ and Hung CF and Yang CK and Wu MJ and Chao CH},
  year = {2026},
  journal = {Cell death \& disease},
  doi = {10.1038/s41419-026-09106-0},
  url = {https://doi.org/10.1038/s41419-026-09106-0}
}

RIS

TY  - JOUR
TI  - ENO2 sustains cancer stemness and metastatic competence through a phosphoenolpyruvate-dependent metabolic axis in triple-negative breast cancer.
AU  - Wang CH
AU  - Mai RT
AU  - Khoo KJ
AU  - Hung CF
AU  - Yang CK
AU  - Wu MJ
AU  - Chao CH
PY  - 2026
JO  - Cell death & disease
DO  - 10.1038/s41419-026-09106-0
UR  - https://doi.org/10.1038/s41419-026-09106-0
ER  - 

APA

CH, W., RT, M., KJ, K., CF, H., CK, Y., MJ, W., & CH, C. (2026). ENO2 sustains cancer stemness and metastatic competence through a phosphoenolpyruvate-dependent metabolic axis in triple-negative breast cancer.. Cell death & disease. https://doi.org/10.1038/s41419-026-09106-0

Source records